Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med. 2012 Nov 08; 367(19):1783-91.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.